artenimol has been researched along with aminolevulinic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Du, J; Du, X; Han, Y; Huang, P; Jiang, C; Li, S; Li, Y; Sui, H | 1 |
| Feng, Y; Hu, H; Li, C; Li, Z; Lu, Y; Teng, M; Wang, Q; Wang, Y; Xiao, Z; Yang, B; Zeng, K | 1 |
2 other study(ies) available for artenimol and aminolevulinic acid
| Article | Year |
|---|---|
Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
Topics: Aminolevulinic Acid; Animals; Artemisinins; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; NF-KappaB Inhibitor alpha; Photochemotherapy; Photosensitizing Agents; RNA Interference; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factors | 2018 |
Dihydroartemisinin administration improves the effectiveness of 5-aminolevulinic acid-mediated photodynamic therapy for the treatment of high-risk human papillomavirus infection.
Topics: Aminolevulinic Acid; Apoptosis; Artemisinins; Cell Line, Tumor; Female; HeLa Cells; Humans; Papillomavirus Infections; Photochemotherapy; Photosensitizing Agents | 2021 |